Effects of consumption of the test food on the immune functio
- Conditions
- Healthy Japanese subjects
- Registration Number
- JPRN-UMIN000044401
- Lead Sponsor
- ORTHOMEDICO Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 22
Not provided
1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," "Foods with Function Claims," 5. Subjects who are currently taking medications (including herbal medicines) and supplements. 6. Subjects who are allergic to medicines and/or vegetables and fruits in general. 7. Subjects who are pregnant, lactation, or planning to become pregnant 8. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 9. Subjects who are diagnosed with pollen allergy 10. Subjects who have an autoimmune disease 11. Subjects who are taking immunosuppressants such as steroids 12. Subjects who have received vaccination for infectious diseases such as influenza within three month 13. Subjects who are diagnosed with hemoglobinemia (iron overload) 14. Subjects who are diagnosed with Wilson's disease 15. Subjects who are ineligibility to participate in the study based on the evaluation of the principal physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. The measured values of scoring of immunological vigor at four weeks after consumption (4w)
- Secondary Outcome Measures
Name Time Method